Daily BriefsUnited States

Daily Brief United States: S&P 500 INDEX, US Energy , Guess? Inc, Natural Gas, Clean Energy Technologies , Abercrombie & Fitch Co Cl A, NEXTracker , Silicon Laboratories, Soligenix , Lantheus Holdings and more

In today’s briefing:

  • S&P 500, Nasdaq 100 Testing Bull Flag Supports; Bullish Breadth Divergences; Buy the Pullback
  • USEG: U.S. Energy acquires additional industrial gas acreage in the Kevin Dome structure in Montana. The company also announced the divesture of certain oil & gas properties in Texas.
  • GES: ICR Conference Notes: Focused on Winning LT: Reiterate Buy and $23 PT
  • [US Nat Gas Options Weekly 2025/02] Henry Hub Surges on Expectations of Robust Heating Demand
  • Sustainable Investing Surveyor – Focus on Clean Energy Technologies, Inc.
  • AKA: ICR Conference Notes: A Holiday Winner; Raising Projections, Reiterate Buy
  • Nextracker Inc.: The Expansion in International Markets & Other Major Drivers
  • Silicon Labs: An Insight Into Its Recent Design Win Ramps & Market Share Growth!
  • SNGX: Additional Positive Outcomes in Investigator-Initiated Study of HyBryte in CTCL
  • LNTH: LMI Acquisition and NeuraCeq


S&P 500, Nasdaq 100 Testing Bull Flag Supports; Bullish Breadth Divergences; Buy the Pullback

By Joe Jasper

  • Rising DXY, Treasury yields, and now energy commodities breaking out (Bloomberg Commodity index $DJP and WTI crude oil) suggests upside is likely to be capped, but…
  • …we still continue to see many other risk-on signals. As a result, we view this pullback as a buying opportunity, with all the major indexes testing/holding at support
  • Looking for support on the S&P 500 at 5850, the 100-day MA (currently 5820), 5765-5770, and 5600-5670. As long as the S&P 500 remains above 5600-5670, our outlook remains bullish

USEG: U.S. Energy acquires additional industrial gas acreage in the Kevin Dome structure in Montana. The company also announced the divesture of certain oil & gas properties in Texas.

By Zacks Small Cap Research

  • U.S. Energy (NASDAQ: USEG) is an independent energy company historically focused on the acquisition and development of oil and natural gas producing properties in the U.S. In June 2024, the company acquired acreage in Montana with the goal of extracting and marketing helium products and other industrial gases.
  • Going forward, the primary focus will be on the development and operation of helium and other industrial gases, along with the development of carbon sequestration capabilities.
  • The company has no debt and $21.15 million in available liquidity.

GES: ICR Conference Notes: Focused on Winning LT: Reiterate Buy and $23 PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating, $23 price target and projections for GUESS?
  • Inc. after meeting with management at the 2025 ICR Conference.
  • We believe management is highly focused on returning Guess?

[US Nat Gas Options Weekly 2025/02] Henry Hub Surges on Expectations of Robust Heating Demand

By Suhas Reddy

  • For the week ending 10/Jan, U.S. natural gas prices surged by 18.9% led by cold weather forecasts, rising LNG exports, supply disruptions, and declining inventories.
  • Henry Hub Put/Call volume ratio fell to 1.29 from 1.37 (03/Jan) the previous week as call volumes rose by 40.3% WoW, while put volumes grew by 32.7%. 
  • Henry Hub OI PCR rose to 0.92 from 0.87 compared to last week. Call OI inched up by 5.4% WoW, while put OI increased by 10.5%.

Sustainable Investing Surveyor – Focus on Clean Energy Technologies, Inc.

By Water Tower Research

  • The WTR Sustainable Index was down 3.1% W/W versus the S&P 500 Index (down 1.9%), the Russell 2000 Index (down 3.5%), and the Nasdaq Index (down 2.2%).
  • Energy Technology (14.0% of the index) was down 3.8%, while Industrial Climate and Ag Technology (46.6% of the index) was down 1.8%, ClimateTech Mining was down 2.9%, and Advanced Transportation Solutions (21.4% of index) was down 5.3%.
  • Top 10 Performers: SPI, BNRG, AZRE, ARVL, TGEN, ARBE, EGT, GP, GCEI, PSI

AKA: ICR Conference Notes: A Holiday Winner; Raising Projections, Reiterate Buy

By Small Cap Consumer Research

  • We are reiterating our Buy rating and $30 price target and raising our projections for a.k.a. Brands after the company updated 4Q24 guidance, removed the interim title from CEO Ciaran Long, announced the expansion of Petal & Pup into all Nordstrom doors, and presented at the ICR Conference.
  • With the majority of the 4Q upside catalysts flowing into 2025, the company on track to launch their first New York City store in 1H25 and the potential for stabilization in the still significant Australian market, we believe our slightly raised 2025 projections remain conservative, and we reiterate or Buy rating and $30 price target for AKA.

Nextracker Inc.: The Expansion in International Markets & Other Major Drivers

By Baptista Research

  • Nextracker’s recent earnings highlight a mix of positive developments and some areas of caution for potential investors in the solar tracking industry.
  • The company has reported another strong quarter with double-digit revenue growth for the seventh consecutive time, underscoring robust operational execution and strong demand for its products across various markets.
  • With a significant revenue increase of 29% year-over-year for the first half of fiscal 2025, Nextracker has demonstrated its ability to capture market share effectively.

Silicon Labs: An Insight Into Its Recent Design Win Ramps & Market Share Growth!

By Baptista Research

  • Silicon Laboratories delivered mixed results for the third quarter of fiscal 2024.
  • The company’s revenue reached $166 million, which marked a 14% sequential increase, although it was down 18% year-over-year due to persisting issues related to excess inventory among distributors and end customers.
  • Despite this decline, Silicon Laboratories managed to surpass the midpoint of its revenue guidance, signaling some resilience in its business operations amidst broader market challenges.

SNGX: Additional Positive Outcomes in Investigator-Initiated Study of HyBryte in CTCL

By Zacks Small Cap Research

  • On January 14, 2025, Soligenix, Inc. (SNGX) announced additional interim data from the open-label, investigator-initiated study (IIS) testing HyBryte treatment in patients with cutaneous T cell lymphoma (CTCL) for up to 12 months.
  • Thus far, nine patients have been enrolled and treated with HyBryte for up to 54 weeks.
  • Over 80% (5/6 that have completed at least 18 weeks of therapy) have already achieved treatment success, which is defined in the study protocol as a =50% improvement in the cumulative mCAILS.

LNTH: LMI Acquisition and NeuraCeq

By Zacks Small Cap Research

  • Zacks Small-Cap Research Note for Lantheus Holdings, Inc. (LNTH)

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars